Clinical trial
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
- Lead sponsor
- National Institute of Cancerología
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2007
- Completion date
- Not reported
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
circulating tumor cells